A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
作者信息
Cornell S
出版信息
Adv Nurse Pract. 2000 Dec;8(12):62-4.
PMID:12397912
Abstract
摘要
相似文献
1
A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
Adv Nurse Pract. 2000 Dec;8(12):62-4.
2
Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther. 2006 Jun 19;48(1237):49-51.
3
Quillivant XR--an extended release oral suspension of methylphenidate.
Med Lett Drugs Ther. 2013 Feb 4;55(1409):10-1.
4
[Methylphenidate. A possibility for rare hyperactive children].
Rev Infirm. 2004 Sep(103):39-40.
5
Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
J Contemp Health Law Policy. 2003 Spring;19(2):495-520.
6
The latest drugs on the FDA's radar.
Behav Healthc. 2006 Jun;26(6):34-5.
7
Linezolid.
Neonatal Netw. 2009 May-Jun;28(3):187-92. doi: 10.1891/0730-0832.28.3.187.
8
Methylphenidate: its pharmacology and uses.
Mayo Clin Proc. 2000 Jul;75(7):711-21. doi: 10.4065/75.7.711.
9
Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Science. 2004 Aug 20;305(5687):1088-9. doi: 10.1126/science.305.5687.1088a.
10
Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
Hum Psychopharmacol. 2004 Apr;19(3):151-80. doi: 10.1002/hup.579.
Zotero 插件